[go: up one dir, main page]

DE69033986D1 - Ungeladene, auf Morpholin basierende Polymere mit Chiralen, Phosphor enthaltenden Brücken zwischen den Untereinheiten - Google Patents

Ungeladene, auf Morpholin basierende Polymere mit Chiralen, Phosphor enthaltenden Brücken zwischen den Untereinheiten

Info

Publication number
DE69033986D1
DE69033986D1 DE69033986T DE69033986T DE69033986D1 DE 69033986 D1 DE69033986 D1 DE 69033986D1 DE 69033986 T DE69033986 T DE 69033986T DE 69033986 T DE69033986 T DE 69033986T DE 69033986 D1 DE69033986 D1 DE 69033986D1
Authority
DE
Germany
Prior art keywords
uncharged
phosphorus
subunit
chiral
subunits
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69033986T
Other languages
English (en)
Other versions
DE69033986T2 (de
Inventor
James E Summerton
Dwight D Weller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sarepta Therapeutics Inc
Original Assignee
Antivirals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antivirals Inc filed Critical Antivirals Inc
Application granted granted Critical
Publication of DE69033986D1 publication Critical patent/DE69033986D1/de
Publication of DE69033986T2 publication Critical patent/DE69033986T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G79/00Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
    • C08G79/02Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule a linkage containing phosphorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Saccharide Compounds (AREA)
  • Polyamides (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69033986T 1989-12-20 1990-12-20 Ungeladene, auf Morpholin basierende Polymere mit Chiralen, Phosphor enthaltenden Brücken zwischen den Untereinheiten Expired - Lifetime DE69033986T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45405789A 1989-12-20 1989-12-20

Publications (2)

Publication Number Publication Date
DE69033986D1 true DE69033986D1 (de) 2002-08-14
DE69033986T2 DE69033986T2 (de) 2003-03-13

Family

ID=23803120

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69033986T Expired - Lifetime DE69033986T2 (de) 1989-12-20 1990-12-20 Ungeladene, auf Morpholin basierende Polymere mit Chiralen, Phosphor enthaltenden Brücken zwischen den Untereinheiten
DE69034213T Expired - Lifetime DE69034213T2 (de) 1989-12-20 1990-12-20 Ungeladene, auf morpholin basierende polymere mit chiralen, phosphor enthaltenden brücken zwischen den untereinheiten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69034213T Expired - Lifetime DE69034213T2 (de) 1989-12-20 1990-12-20 Ungeladene, auf morpholin basierende polymere mit chiralen, phosphor enthaltenden brücken zwischen den untereinheiten

Country Status (8)

Country Link
EP (2) EP0962463B1 (de)
JP (2) JP3398378B2 (de)
KR (1) KR0167574B1 (de)
AT (2) ATE220407T1 (de)
AU (1) AU655164B2 (de)
CA (1) CA2069869C (de)
DE (2) DE69033986T2 (de)
WO (1) WO1991009033A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405938A (en) * 1989-12-20 1995-04-11 Anti-Gene Development Group Sequence-specific binding polymers for duplex nucleic acids
US5166315A (en) * 1989-12-20 1992-11-24 Anti-Gene Development Group Sequence-specific binding polymers for duplex nucleic acids
AU7135498A (en) * 1997-04-17 1998-11-11 Antivirals Inc. Method of treating restenosis by antisense targeting of cmv
US20010024783A1 (en) * 1999-01-29 2001-09-27 Avi Biopharma, Inc. Non-invasive method for detecting target RNA
KR20010102992A (ko) * 1999-01-29 2001-11-17 추후보정 표적 rna를 검출하는 비-침입적 방법
US6875747B1 (en) 1999-05-24 2005-04-05 Avi Bio Pharma, Inc. Antisense to c-myc for treatment of polycystic kidney disease
JP2003500418A (ja) * 1999-05-24 2003-01-07 エイブイアイ バイオファーマ, インコーポレイテッド 多発性嚢胞腎疾患の処置のためのc−mycに対するアンチセンス
ATE393221T1 (de) 1999-11-29 2008-05-15 Avi Biopharma Inc Gegen bakterielle 16s und 23s rrnas gerichtete ungeladene antisense oligonukleotide und deren verwendungen
AU781676B2 (en) * 2000-01-04 2005-06-02 Avi Biopharma, Inc. Antisense antibacterial cell division composition and method
WO2006085973A2 (en) 2004-07-02 2006-08-17 Avi Biopharma, Inc. Antisense antibacterial method and compound
US8067571B2 (en) 2005-07-13 2011-11-29 Avi Biopharma, Inc. Antibacterial antisense oligonucleotide and method
DK2024499T3 (da) * 2006-05-10 2018-01-29 Sarepta Therapeutics Inc Oligonukleotidanaloger med kationiske intersubunit-koblinger
EP2207779B1 (de) * 2007-11-15 2014-04-09 Sarepta Therapeutics, Inc. Verfahren zur synthese von morpholino-oligomeren
AU2013202731B2 (en) * 2010-05-28 2016-04-21 Sarepta Therapeutics, Inc. Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
EP2576574A2 (de) * 2010-05-28 2013-04-10 Sarepta Therapeutics, Inc. Oligonucleotidanaloga mit modifizierten interuntereinheitenkopplungen und/oder entständigen gruppen
TWI541024B (zh) 2010-09-01 2016-07-11 日本新藥股份有限公司 反義核酸
WO2012031243A2 (en) 2010-09-03 2012-03-08 Avi Biopharma, Inc. dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
LT2623507T (lt) 2010-09-30 2017-01-25 Nippon Shinyaku Co., Ltd. Morfolino nukleorūgšties darinys
KR102271212B1 (ko) 2011-11-18 2021-07-01 사렙타 쎄러퓨틱스, 인코퍼레이티드 기능적으로-변형된 올리고뉴클레오티드 및 이의 서브유니트
AU2012360702C1 (en) 2011-12-28 2018-09-20 National Center Of Neurology And Psychiatry Antisense nucleic acid
EA031110B1 (ru) 2012-03-20 2018-11-30 Сарепта Терапьютикс, Инк. Конъюгаты бороновых кислот олигонуклеотидных аналогов
DK3015467T3 (da) 2013-05-24 2025-02-10 Ajinomoto Kk Morpholino-oligonukleotidfremstillingsfremgangsmåde
SMT201900169T1 (it) 2014-03-12 2019-05-10 Nippon Shinyaku Co Ltd Acido nucleico antisenso
TWI721461B (zh) 2014-06-17 2021-03-11 日商日本新藥股份有限公司 反義核酸
EP3208277A4 (de) * 2014-10-14 2018-06-13 Ajinomoto Co., Inc. Morpholin-oligonukleotid-herstellungsverfahren
CN113717239B (zh) 2015-01-21 2024-12-24 味之素株式会社 沉淀促进剂以及使用其的沉淀方法
US11020417B2 (en) 2015-06-04 2021-06-01 Sarepta Therapeutics, Inc Methods and compounds for treatment of lymphocyte-related diseases and conditions
PL3351633T3 (pl) 2015-09-15 2020-11-02 Nippon Shinyaku Co., Ltd. Antysensowny kwas nukleinowy
US10563199B2 (en) 2015-09-16 2020-02-18 Nippon Shinyaku Co., Ltd. Antisense nucleic acid for treating amyotrophy
AU2017330276B2 (en) * 2016-09-20 2022-01-20 The Regents Of The University Of Colorado, A Body Corporate Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry
WO2019216433A1 (ja) 2018-05-10 2019-11-14 日本新薬株式会社 オリゴ核酸化合物の製造方法
CA3101321A1 (en) 2018-06-26 2020-01-02 Nippon Shinyaku Co., Ltd. Composition comprising antisense oligonucleotide and use thereof for treatment of duchenne muscular dystrophy
GB201821269D0 (en) 2018-12-28 2019-02-13 Nippon Shinyaku Co Ltd Myostatin signal inhibitor
EP4059944A4 (de) 2019-11-13 2024-04-10 Nippon Shinyaku Co., Ltd. Verfahren zur herstellung einer oligonukleidsäureverbindung
JP7669280B2 (ja) 2019-11-13 2025-04-28 日本新薬株式会社 オリゴ核酸化合物の製造方法
JPWO2021125311A1 (de) 2019-12-19 2021-06-24
AU2020411964A1 (en) 2019-12-26 2022-06-16 National Center Of Neurology And Psychiatry Antisense nucleic acid that induces skipping of exon 50
BR112022017066A2 (pt) 2020-02-28 2022-11-16 Nippon Shinyaku Co Ltd Ácido nucleico antissentido indutor de salto do éxon 51
EP4320138A1 (de) 2021-04-09 2024-02-14 Bachem Holding AG Pseudofestphase-schutzgruppe und verfahren zur synthese von oligonukleotiden und oligonukleotidkonjugaten
AU2022266379A1 (en) 2021-04-28 2023-11-09 Nippon Shinyaku Co., Ltd. Method for producing oligonucleic acid compound
JPWO2022239863A1 (de) 2021-05-13 2022-11-17
AU2022279820A1 (en) 2021-05-28 2023-12-14 Sumitomo Pharma Co., Ltd. Antisense nucleic acid
EP4361269A1 (de) 2021-06-23 2024-05-01 Nippon Shinyaku Co., Ltd. Kombination von antisense-oligomeren
KR20240035502A (ko) 2021-07-08 2024-03-15 니뽄 신야쿠 가부시키가이샤 신독성 경감제
CN118434424A (zh) 2021-07-08 2024-08-02 日本新药株式会社 析出抑制剂
WO2023282344A1 (ja) 2021-07-08 2023-01-12 日本新薬株式会社 腎毒性軽減剤
EP4389893A4 (de) 2021-08-21 2025-09-10 Takeda Pharmaceuticals Co Peptid-wirkstoff-konjugat, das an den menschlichen transferrin-rezeptor bindet
KR20240129006A (ko) 2021-12-27 2024-08-27 니뽄 신야쿠 가부시키가이샤 올리고 핵산 화합물의 제조 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216860B1 (de) * 1985-03-15 1992-10-28 SUMMERTON, James Stereoregulare polynukleotiden bindende polymere

Also Published As

Publication number Publication date
KR920703584A (ko) 1992-12-18
EP0506830A4 (en) 1993-01-07
AU7164291A (en) 1991-07-18
DE69034213D1 (de) 2006-01-19
DE69034213T2 (de) 2006-08-24
EP0962463A1 (de) 1999-12-08
EP0506830B1 (de) 2005-12-14
DE69033986T2 (de) 2003-03-13
JP3398378B2 (ja) 2003-04-21
WO1991009033A1 (en) 1991-06-27
CA2069869C (en) 1995-12-19
KR0167574B1 (ko) 1999-01-15
JP2002167441A (ja) 2002-06-11
CA2069869A1 (en) 1991-06-21
ATE312834T1 (de) 2005-12-15
ATE220407T1 (de) 2002-07-15
EP0506830A1 (de) 1992-10-07
AU655164B2 (en) 1994-12-08
EP0962463B1 (de) 2002-07-10
JPH05504563A (ja) 1993-07-15

Similar Documents

Publication Publication Date Title
DE69033986D1 (de) Ungeladene, auf Morpholin basierende Polymere mit Chiralen, Phosphor enthaltenden Brücken zwischen den Untereinheiten
ATE164081T1 (de) Ungeladene polymere mit morpholino-einheiten und mit achiralen bindungen zwischen diesen einheiten
ATE81872T1 (de) Stereoregulare polynukleotiden bindende polymere.
DE69023846D1 (de) Styrencopolymer und verfahren zur herstellung.
HUT62010A (en) Process for producing oligonucleotide analogs comprising terminal 3 - 3, or 5 - 5- intermolecular bonds
ES2093016T3 (es) Composicion suavizante de tejidos.
DE3789296D1 (de) Polyimid mit Formstabilität beim Erhitzen.
FR2603579B1 (fr) Procede d'hydroformylation utilisant des ligands phosphiniques peu volatils, solubles en milieu organique
ATE77959T1 (de) Tumor-nekrose-faktor-formulierung und ihre herstellung.
BR8706365A (pt) Novos polimeros de monoxido de carbono com um ou mais compostos alfa-olefinicamente nao-saturados,e,processo para a preparacao dos mesmos
DE3577106D1 (de) Verwendung von pulverfoermigen beschichtungsmitteln auf der basis von polyamiden mit durchschnittlich mindestens neun kohlenstoffatomen pro carbonamidgruppe.
ATE116080T1 (de) Dekodierung von zufallssequenzen.
ATE136321T1 (de) Polyarylensulfid-harzzusammensetzung
DK0603813T3 (da) Formlegemer af copolyamider med langkædede polyamidenheder
ES2147280T3 (es) Remate de polimeros anionicos con oxetanos.
ATE177128T1 (de) Mit phosphorverbindungen und einer polyolefinezusammensetzung modifiziertes bitumen
MX9303428A (es) Resina entrelazada novedosa absorbedora de agua.
ATE152112T1 (de) Oxamidstabilisatoren
DE69823129D1 (de) Verfahren zur Herstellung von Polyamiden
ES2055773T3 (es) Combinaciones de aglutinantes y un procedimiento para la obtencion de formaciones superficiales.
IT1212123B (it) Nuovi composti polimerici contenenti gruppi piperidinici, utilizzabili come stabilizzanti per polimeri sintetici.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition